Vantage Consulting Group’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,991
Closed -$408K 35
2024
Q2
$408K Buy
2,991
+372
+14% +$51.7K 0.3% 39
2024
Q1
$401K Sell
2,619
-216
-8% -$32.2K 0.26% 47
2023
Q4
$404K Buy
2,835
+106
+4% +$14.1K 0.27% 45
2023
Q3
$358K Sell
2,729
-395
-13% -$60K 0.24% 55
2023
Q2
$497K Sell
3,124
-269
-8% -$43.4K 0.29% 37
2023
Q1
$537K Sell
3,393
-58
-2% -$8.7K 0.3% 30
2022
Q4
$484K Sell
3,451
-235
-6% -$33.4K 0.29% 40
2022
Q3
$473K Sell
3,686
-214
-5% -$30.9K 0.28% 39
2022
Q2
$550K Buy
3,900
+152
+4% +$21.7K 0.31% 17
2022
Q1
$521K Buy
3,748
+471
+14% +$72.2K 0.2% 27
2021
Q4
$571K Buy
3,277
+220
+7% +$36.7K 0.15% 30
2021
Q3
$506K Buy
3,057
+162
+6% +$27.9K 0.11% 30
2021
Q2
$521K Buy
2,895
+1,021
+54% +$186K 0.09% 29
2021
Q1
$361K Buy
1,874
+700
+60% +$135K 0.07% 33
2020
Q4
$237K Buy
+1,174
New +$243K 0.02% 38

Other funds holding CLX

Vantage Consulting Group's CLX Position: Q3 2024 in Review

Vantage Consulting Group sold out of Clorox (CLX) in Q3 2024, closing a stake of 2,991 shares — an estimated $408K sold.

Vantage Consulting Group first reported a position in CLX in Q4 2020 and held it in 15 quarters. The position peaked at $571K in Q4 2021. 1,151 funds tracked by Wall St. Rank hold CLX as of Q3 2024.

  • Vantage Consulting Group reported no remaining Clorox position as of Q3 2024 after selling out during the quarter.
  • Vantage Consulting Group sold 2,991 Clorox shares in Q3 2024, an estimated $408K.
  • Vantage Consulting Group first reported a position in Clorox in Q4 2020 and held it in 15 quarters.
  • Vantage Consulting Group's Clorox position peaked at $571K in Q4 2021.
  • 1,151 funds tracked by Wall St. Rank held Clorox as of Q3 2024.

Based on Vantage Consulting Group's 13F filing for Q3 2024, filed 14 Nov 2024.